Translate this page into:
1H and 13C NMR spectra of condensed benzimidazole and imidazobenzodiazepines
*Corresponding author. Tel.: +212 523343003; fax: +212 523342187 elkihelabdellatif1@yahoo.fr (A. El kihel)
-
Received: ,
Accepted: ,
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
Available online 23 September 2010
Abstract
Benzimidazoles are heterocyclic compounds that have awakened great interest during the last few years because of their proven biological activity as antiviral, antimicrobial, and antitumoral agents. For this reason, the development of a systematic NMR study of condensed benzimidazole compounds constitutes a significant tool in understanding the molecular dynamics and the structural parameters that govern their behavior. The 1H and 13C NMR spectra of new imidazobenzodiazepines were investigated. Based on the study of NMR chemical shifts, we discuss the environmental effect of the nucleus 13C. The correlation 1H–13C proved to be a useful method for distinguishing the assignment of carbon.
Keywords
Benzimidazole
Imidazobenzodiazepines
1H and 13C NMR
1H–13C correlation
1 Introduction
The benzimidazole nucleus and its derivatives are known to play extremely crucial roles in the structures and functions of a number of biologically important molecules, generally by virtue of their being coordinated to metal ions. The incorporation of the benzimidazole nuclei is an important synthetic strategy in drug discovery (Townsend, 1976). The high therapeutic properties of the related drugs have encouraged the medicinal chemists to synthesize the large number of novel chemotherapeutic agents (Kleeman et al., 1999). Pharmaceutical properties including: antiviral (Cheng et al., 2005), antitumoral (Yang et al., 2009; Charlson et al., 1973), antifungal and antimycotic (Walker et al., 1978), antihistaminic and antiallergic (Nakano et al., 2000), antimicrobial (Marquis et al., 2006), antihelminthic (Mavrova, 2006) and spasmolytic activity (Navarrete-Vázquez et al., 2006). These different applications have attracted many experimentalists and theorists to investigate the spectroscopic and structural properties of benzimidazole (Mohan, 1991; Klots et al., 1997; Morsy et al., 2002) and some of its derivatives (Yurdakul and Yilmaz, 1999).
In this work, we report the study of NMR spectra of condensed benzimidazoles. We have previously described the synthesis of 4-(2,5,6-trimethyl-1H-benzo[d]imidazol-7-ylamino)pent-3-en-2-one 1a, ethyl 3-(2,5,6-trimethyl-1H-benzo[d]imidazol-7-ylamino)but-2-enoate 1b, 4-acetonylidene-5-acetyl-2,6,8,9-tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzodiazepine 2a and 4-acetonylidene-5-ethoxycarbonyl-2,6,8,9-tetramethyl-7H-imidazo-[1,5,4-e,f][1,5]-benzodiazepine 2b (El kihel et al., 2008). The NMR parameters of these heterocycles are reported in this paper.
2 Results and discussion
A variety of works are reported about the NMR of benzimidazole derivatives (Embrey and Craik, 1995; Infante-Castillo et al., 2008; El kihel et al., 2005) The 13C NMR spectra and the charge density of carbon for the benzimidazole were reported by Pugmire and Grant (1971). The chemical shifts of carbon 13 for some benzimidazoles substituted in position 5 were published (Mathias and Overberger, 1978; Fruchier et al., 1980; Blackburn et al., 1982; Lopyrev et al., 1981, 1985). Other works have reported the NMR of some bisbenzimidazoles and condensed benzimidazoles (Dall’Oglio et al., 2002; Alcade et al., 1991; Goljer et al., 1985). After the study of the behavior of the 13C NMR spectra in the benzimidazole series (Goljer et al., 1985), we are interested to report our contribution in this area by using NMR spectroscopy for the elucidation of carbon13 chemical shifts of these benzimidazole derivatives. We have studied the influence of the substituents on the 13C NMR spectra of these compounds. The complete assignment of the resonances of the 13C NMR spectra of the benzimidazole derivatives was carried out by selective decoupling, NOE, and H, C-COSY experiments (see Figs. 1 and 2).The numbering of the compunds for the 1HNMR assignments.
The numbering of the compounds for the 13CNMR assignments.
3 Results and discussion
Tables 1 and 2 give the 1H and 13C NMR data, respectively; of 1a, 1b, 2a and 2b.
Proton
Compounds
1a
1b
2a
2b
H1
10.19(br s, cyclic NH)
9.99(br s, cyclic NH)
H4
7.21(s)
7.22(s)
7.36(s)
7.43(s)
H10
2.44(s, CH3)
2.45(s, CH3)
2.54(s, CH3)
2.45(s, CH3)
H11
2.31(s, CH3)
2.33(s, CH3)
2.42(s, CH3)
2.37(s, CH3)
H12
2.00(s, CH3)
2.10(s, CH3)
1.95(s, CH3)
1.67(s, CH3)
H14
5.25(s, olefinic H)
4.69(s, olefinic H)
H16
1.87(s, CH3)
1.22(t, CH3),
1.79(s, CH3)
1.24(t, CH3)
4.07(q, CH2)
4.21(q, CH2)
H17
2.13(s, CH3)
2.16(s, CH3)
2.37(s, CH3)
1.95(s, CH3)
H18
12.23(s, NH)
12.32(s, NH)
15.81(s, NH)
12.54(s, NH)
H19
6.20(s, olefinic H)
6.28(s, olefinic H)
H21
1.80(s, CH3)
1.69(s, CH3)
Carbon
Compounds chemical shifts (ppm)
1a
1b
2a
2b
C2
150.8
159.6
145.2
146.7
C4
110.2
110.2
99.7
112.9
C5
129.8
126.4
132.3
131.1
C6
124.8
117.2
126.8
125.9
C7
130.1
130.1
134.3
133.6
C8
125.6
120.8
128.4
126.1
C9
147.5
150.5
139.1
138.0
C10
14.5
20.6
14.4
14.4
C11
20.5
19.5
18.2
17.1
C12
13.8
14.5
13.3
13.9
C13
162.7
161.6
147.3
149.8
C14
95.8
83.0
124.7
123.5
C15
194.4
169.7
204.1
166.8
C16
38.5
18.3, 57.8
20.1
13.1, 60.7
C17
28.7
48.6
19.2
19.6
C18
154.1
152.6
C19
105.1
116.6
C20
173.3
174.1
C21
20.3
20.3
The benzimidazole presents a rapid tautomerism which does not allow to obtain all expected signals in the 13C NMR spectra in the case of substituted benzimidazoles by heterocycles(El Kihel et al., 2005).
This phenomenon was not observed for the open chain intermediates 1a and 1b or the condensed benzimidazoles 2a and 2b, the 13C NMR spectra of these compounds present all the expected signals.
For the condensed benzimidazoles as imidazobenzodiazepines, we have studied the chemical shifts of vinyl and carbonyl group in order to see the effect of conjugated system.
For the 13C NMR spectra of compounds 2a and 2b, the conjugated system induces a systematic shielding of the carbonyl group in position 20 (δ = 173.3 ppm for compound 2a and δ = 174.1 ppm for compound 2b) by comparison of the chemical shifts of the carbonyl group in position 15 (δ = 194.4 ppm for compound 1a and δ = 204.1 ppm for compound 2a) while the same observation applies to the carbonyl group of ester with less shielding (δ = 169.7 ppm for compound 1b, δ = 166.8 ppm for compound 2b). We also noted the deshielding of vinyl group CH in compounds 2a and 2b (δ = 105.1 ppm for compound 2a and δ = 116.6 ppm for compound 2b) by comparison of that in compounds 1a and 1b (δ = 95.8 ppm for compound 1a and δ = 83.0 ppm for compound 1b).
4 Experimental section
All compounds were characterized by their 1H NMR and 13C NMR spectra as well as by microanalysis or HRMS spectra. NMR spectra were recorded on Bruker ARX 200 (200 MHz for 1H and 50.3 MHz for 13C) spectrometer (Ω-ppm/TMS, J-Hz); for 13C NMR, the multiplicities were determined through DEPT.
References
- Eur. J. Med. Chem.. 1991;26:633.
- Can. J. Chem.. 1982;60:2987.
- J. Carbohydr. Res.. 1973;29:89.
- Bioorg. Med. Chem. Lett.. 2005;17:267.
- J. Braz. Chem. Soc.. 2002;13(2):251.
- Phys. Chem. News. 2005;25:130.
- Synthetic Commun.. 2008;38:201.
- J. Phys. Chem.. 1995;99:4831.
- Ann. Quim.. 1980;76:79.
- Magn. Reson. Chem.. 1985;23(10):877.
- J. Mol. Struct.. 2008;877:10-19.
- Kleeman, A., Engel, J., Kutscher, B., Reichert, D., 1999. Pharmaceutical Substances, third ed., Thieme, Stuttgart, New York, p. 726.
- Spectrochim. Acta A. 1997;53:2445.
- Org. Magn. Reson.. 1981;15:219.
- Magn. Reson. Chem.. 1985;23:301-304.
- Arch. Oral Biol.. 2006;51:1015.
- J. Org. Chem.. 1978;43:3526.
- Eur. J. Med. Chem.. 2006;41:1412.
- Spectrochim. Acta A. 1991;47:1111.
- J. Phys. Chem. A. 2002;106:9196.
- Bioorg. Med. Chem.. 2000;8:373.
- Bioorg. Med. Chem. Lett.. 2006;16:4169-4173.
- J. Am. Chem. Soc.. 1971;93:1880.
- Chem. Rev.. 1976;67:533.
- Med. Chem.. 1978;21:840.
- Eur. J. Med. Chem.. 2009;44:1808-1812.
- Vib. Spectrosc.. 1999;21:127.